Depression in Parkinson's disease: An update

Jeana L. Benton; Steven P. Wengel; William J. Burke

doi:10.1007/978-1-60761-429-6_1

Depression in Parkinson's disease: An update

Jeana L. Benton, Steven P. Wengel, William J. Burke

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Depression is the most common psychological disturbance that affects people with Parkinson's disease (PD). Despite an increasing amount of research devoted to this topic, uncertainty still exists concerning many aspects of depression in PD. Significant questions remain regarding some very basic issues, including how best to diagnose depression in PD, how frequently depression complicates PD, the risk factors for developing depression, and how best to treat depression. This chapter provides a current perspective on what is known about depression in PD, reviewing its epidemiology, etiology, and treatment. Rather than providing a comprehensive overview, the focus here is on updating the major themes of research in this field.

Original language	English (US)
Title of host publication	Parkinson's Disease and Nonmotor Dysfunction
Subtitle of host publication	Second Edition
Publisher	Humana Press Inc.
Pages	3-15
Number of pages	13
ISBN (Electronic)	9781607614296
ISBN (Print)	9781607614289
DOIs	https://doi.org/10.1007/978-1-60761-429-6_1
State	Published - Jan 1 2013

Keywords

Depression
Dysthymia
Electroconvulsive therapy
Mania
Mesocorticolimbic pathway
Nortriptyline
Parkinson's disease
Paroxetine
Pramipexole
Selective serotonin reuptake inhibitor
Subthalamic nucleus deep brain stimulation
Tricyclic anti-depressant

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-1-60761-429-6_1

Cite this

@inbook{e6804784c2484efb8f9f52aea7473098,

title = "Depression in Parkinson's disease: An update",

abstract = "Depression is the most common psychological disturbance that affects people with Parkinson's disease (PD). Despite an increasing amount of research devoted to this topic, uncertainty still exists concerning many aspects of depression in PD. Significant questions remain regarding some very basic issues, including how best to diagnose depression in PD, how frequently depression complicates PD, the risk factors for developing depression, and how best to treat depression. This chapter provides a current perspective on what is known about depression in PD, reviewing its epidemiology, etiology, and treatment. Rather than providing a comprehensive overview, the focus here is on updating the major themes of research in this field.",

keywords = "Depression, Dysthymia, Electroconvulsive therapy, Mania, Mesocorticolimbic pathway, Nortriptyline, Parkinson's disease, Paroxetine, Pramipexole, Selective serotonin reuptake inhibitor, Subthalamic nucleus deep brain stimulation, Tricyclic anti-depressant",

author = "Benton, {Jeana L.} and Wengel, {Steven P.} and Burke, {William J.}",

year = "2013",

month = jan,

day = "1",

doi = "10.1007/978-1-60761-429-6_1",

language = "English (US)",

isbn = "9781607614289",

pages = "3--15",

booktitle = "Parkinson's Disease and Nonmotor Dysfunction",

publisher = "Humana Press Inc.",

}

TY - CHAP

T1 - Depression in Parkinson's disease

T2 - An update

AU - Benton, Jeana L.

AU - Wengel, Steven P.

AU - Burke, William J.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Depression is the most common psychological disturbance that affects people with Parkinson's disease (PD). Despite an increasing amount of research devoted to this topic, uncertainty still exists concerning many aspects of depression in PD. Significant questions remain regarding some very basic issues, including how best to diagnose depression in PD, how frequently depression complicates PD, the risk factors for developing depression, and how best to treat depression. This chapter provides a current perspective on what is known about depression in PD, reviewing its epidemiology, etiology, and treatment. Rather than providing a comprehensive overview, the focus here is on updating the major themes of research in this field.

AB - Depression is the most common psychological disturbance that affects people with Parkinson's disease (PD). Despite an increasing amount of research devoted to this topic, uncertainty still exists concerning many aspects of depression in PD. Significant questions remain regarding some very basic issues, including how best to diagnose depression in PD, how frequently depression complicates PD, the risk factors for developing depression, and how best to treat depression. This chapter provides a current perspective on what is known about depression in PD, reviewing its epidemiology, etiology, and treatment. Rather than providing a comprehensive overview, the focus here is on updating the major themes of research in this field.

KW - Depression

KW - Dysthymia

KW - Electroconvulsive therapy

KW - Mania

KW - Mesocorticolimbic pathway

KW - Nortriptyline

KW - Parkinson's disease

KW - Paroxetine

KW - Pramipexole

KW - Selective serotonin reuptake inhibitor

KW - Subthalamic nucleus deep brain stimulation

KW - Tricyclic anti-depressant

UR - http://www.scopus.com/inward/record.url?scp=85028883679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028883679&partnerID=8YFLogxK

U2 - 10.1007/978-1-60761-429-6_1

DO - 10.1007/978-1-60761-429-6_1

M3 - Chapter

AN - SCOPUS:85028883679

SN - 9781607614289

SP - 3

EP - 15

BT - Parkinson's Disease and Nonmotor Dysfunction

PB - Humana Press Inc.

ER -

Depression in Parkinson's disease: An update

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this